Using additional cell lines established from human melanomas resistant to immunotherapy (patients no. 58 and no. 33), we confirmed that these melanomas harbored ROCK-dependent p-MLC2 levels (Figures 5D and S5D). Here, MYL2 is linked to melanoma.